News
IICT transfers Favipiravir production process to Cipla; develops low cost Covid-19 test kit
Indian Institute of Chemical Technology has developed a cost-effective synthetic process for producing antiviral drug Favipiravir and has also developed an affordable RT-PCR kit.
Glenmark receives DCGI approval to conduct trials in India on Favipiravir antiviral tablets for COVID-19 patients
The product is a generic version of Avigan of Fujifilm Toyama. Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.
